Osiris: Columbia biotech company that makes skin substitutes is sold to a London-based firm

The sale of one of Maryland's most promising, but also once-troubled biotechnology companies, Osiris Therapeutics Inc., to a British medical equipment maker is complete, the Columbia-based company announced.Smith & Nephew plc paid $660 million for Osiris, which focuses on developing and marketing...